{
  "pmcid": "5079604",
  "config": {
    "model": "gemini",
    "strategy": "few-shot"
  },
  "usage": {
    "input": 16891,
    "output": 1173
  },
  "raw_text": "```json\n{\"extractions\":[\n  {\n    \"outcome\": \"Disposition index (DI)\",\n    \"intervention\": \"subjects who remained in remission\",\n    \"comparator\": \"patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si)\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": null,\n    \"comparator_events\": null,\n    \"comparator_group_size\": null,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null\n  },\n  {\n    \"outcome\": \"incremental area under the curve for insulin (AUCi)\",\n    \"intervention\": \"subjects who remained in remission\",\n    \"comparator\": \"patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si)\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": null,\n    \"comparator_events\": null,\n    \"comparator_group_size\": null,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null\n  },\n  {\n    \"outcome\": \"hyperglycemia relapse-free survival\",\n    \"intervention\": \"metformin 1,000 mg daily\",\n    \"comparator\": \"sitagliptin 100 mg daily\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": null,\n    \"comparator_events\": null,\n    \"comparator_group_size\": null,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null\n  },\n  {\n    \"outcome\": \"Cox proportional hazards of failure-free survival\",\n    \"intervention\": \"metformin 1,000 mg daily\",\n    \"comparator\": \"sitagliptin 100 mg daily\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": null,\n    \"comparator_events\": null,\n    \"comparator_group_size\": null,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null\n  },\n  {\n    \"outcome\": \"The restricted mean time to hyperglycemia relapse\",\n    \"intervention\": \"metformin 1,000 mg daily, sitagliptin 100 mg daily\",\n    \"comparator\": \"placebo\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": 33,\n    \"comparator_events\": null,\n    \"comparator_group_size\": 15,\n    \"intervention_mean\": 480.0,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": 305.0,\n    \"comparator_standard_deviation\": null\n  },\n  {\n    \"outcome\": \"Hyperglycemia relapse-free survival\",\n    \"intervention\": \"metformin 1,000 mg daily, sitagliptin 100 mg daily\",\n    \"comparator\": \"placebo\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": null,\n    \"comparator_events\": null,\n    \"comparator_group_size\": null,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null\n  },\n  {\n    \"outcome\": \"The 2-year failure rate\",\n    \"intervention\": \"metformin 1,000 mg daily, sitagliptin 100 mg daily\",\n    \"comparator\": \"placebo\",\n    \"outcome_type\": \"binary\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": null,\n    \"comparator_events\": null,\n    \"comparator_group_size\": null,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null\n  },\n  {\n    \"outcome\": \"The probability of relapse\",\n    \"intervention\": \"metformin 1,000 mg daily, sitagliptin 100 mg daily\",\n    \"comparator\": \"placebo\",\n    \"outcome_type\": \"binary\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": null,\n    \"comparator_events\": null,\n    \"comparator_group_size\": null,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null\n  }\n]}\n```",
  "extraction": [
    {
      "outcome": "Disposition index (DI)",
      "intervention": "subjects who remained in remission",
      "comparator": "patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": null,
      "comparator_events": null,
      "comparator_group_size": null,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "5079604"
    },
    {
      "outcome": "incremental area under the curve for insulin (AUCi)",
      "intervention": "subjects who remained in remission",
      "comparator": "patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": null,
      "comparator_events": null,
      "comparator_group_size": null,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "5079604"
    },
    {
      "outcome": "hyperglycemia relapse-free survival",
      "intervention": "metformin 1,000 mg daily",
      "comparator": "sitagliptin 100 mg daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": null,
      "comparator_events": null,
      "comparator_group_size": null,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "5079604"
    },
    {
      "outcome": "Cox proportional hazards of failure-free survival",
      "intervention": "metformin 1,000 mg daily",
      "comparator": "sitagliptin 100 mg daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": null,
      "comparator_events": null,
      "comparator_group_size": null,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "5079604"
    },
    {
      "outcome": "The restricted mean time to hyperglycemia relapse",
      "intervention": "metformin 1,000 mg daily, sitagliptin 100 mg daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 33,
      "comparator_events": null,
      "comparator_group_size": 15,
      "intervention_mean": 480.0,
      "intervention_standard_deviation": null,
      "comparator_mean": 305.0,
      "comparator_standard_deviation": null,
      "pmcid": "5079604"
    },
    {
      "outcome": "Hyperglycemia relapse-free survival",
      "intervention": "metformin 1,000 mg daily, sitagliptin 100 mg daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": null,
      "comparator_events": null,
      "comparator_group_size": null,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "5079604"
    },
    {
      "outcome": "The 2-year failure rate",
      "intervention": "metformin 1,000 mg daily, sitagliptin 100 mg daily",
      "comparator": "placebo",
      "outcome_type": "binary",
      "intervention_events": null,
      "intervention_group_size": null,
      "comparator_events": null,
      "comparator_group_size": null,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "5079604"
    },
    {
      "outcome": "The probability of relapse",
      "intervention": "metformin 1,000 mg daily, sitagliptin 100 mg daily",
      "comparator": "placebo",
      "outcome_type": "binary",
      "intervention_events": null,
      "intervention_group_size": null,
      "comparator_events": null,
      "comparator_group_size": null,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "5079604"
    }
  ]
}